Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Altmeyer Anne. Officer active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. In total, 6 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €28k. Activity tracked since 30 May 2024. The latest transaction was filed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Altmeyer Anne is a Director of Corbus Pharmaceuticals Holdings, Inc. (XNAS). She has 6 filings in total, and across the sampled recent filings from 2024-06-03 to 2026-06-11, sales total 27534 EUR, with the modal transaction nature listed as sale.